<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33555548</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-1182</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Molecular neurobiology</Title><ISOAbbreviation>Mol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>Serum Creatinine Protects Against Amyotrophic Lateral Sclerosis: a Mendelian Randomization Study.</ArticleTitle><Pagination><StartPage>2910</StartPage><EndPage>2915</EndPage><MedlinePgn>2910-2915</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12035-021-02309-w</ELocationID><Abstract><AbstractText>Association between serum creatinine (sCr) and amyotrophic lateral sclerosis (ALS) has been reported in previous observational studies, but results are at risk of confounding bias and reverse causation. Therefore, whether such association is casual remains unclear. Herein, we performed a two-sample Mendelian randomization study to evaluate the causal relationship between sCr and ALS in both European and East Asian populations. Our analysis was conducted using summary statistics from genome-wide association studies with 358,072 individuals for sCr and 80,610 individuals for ALS in European population, and 142,097 individuals for sCr and 4,084 individuals for ALS in East Asian population. The inverse-variance weighted method was used to estimate the casual-effect of sCr on ALS in both populations, and other MR methods were also performed as sensitivity analyses. We found evidence that genetically predicted sCr was inversely associated with risk of ALS (OR, 0.92; 95% CI, 0.85-0.99; P = 0.028) in European population. However, there was no strong evidence for a causal relationship between sCr and ALS in East Asian population (OR, 0.92; 95% CI, 0.84-1.01; P = 0.084). This study provides evidence that sCr protects against ALS in European population but not in East Asian population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Mengmeng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Third Affiliated Hospital of Soochow University, Changzhou, China. w935017050@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Dandan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Geriatrics, The Third Affiliated Hospital of Soochow University, Changzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhizhong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Third Affiliated Hospital of Soochow University, Changzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Liping</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Third Affiliated Hospital of Soochow University, Changzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Linfeng</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Third Affiliated Hospital of Soochow University, Changzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Third Affiliated Hospital of Soochow University, Changzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheng</LastName><ForeName>Shiying</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Third Affiliated Hospital of Soochow University, Changzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lian</LastName><ForeName>Xuegan</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0001-9091-7581</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The Third Affiliated Hospital of Soochow University, Changzhou, China. lxgneuro@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CJ20190085</GrantID><Agency>Applied Basic Research Project of Changzhou Science and Technology Bureau</Agency><Country/></Grant><Grant><GrantID>CE20195042</GrantID><Agency>Science and Technology Bureau of Changzhou</Agency><Country/></Grant><Grant><GrantID>ZD201904</GrantID><Agency>Major Science and Technology Projects of Changzhou Health Commission</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Neurobiol</MedlineTA><NlmUniqueID>8900963</NlmUniqueID><ISSNLinking>0893-7648</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian People</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057182" MajorTopicYN="Y">Mendelian Randomization Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044465" MajorTopicYN="N">White People</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Mendelian randomization</Keyword><Keyword MajorTopicYN="N">Serum creatinine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>8</Day><Hour>12</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33555548</ArticleId><ArticleId IdType="doi">10.1007/s12035-021-02309-w</ArticleId><ArticleId IdType="pii">10.1007/s12035-021-02309-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown RH, Al-Chalabi A (2017) Amyotrophic lateral sclerosis. New England Journal of Medicine 377(2):162&#x2013;172. https://doi.org/10.1056/NEJMra1603471</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, White LA (2013) Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 41(2):118&#x2013;130. https://doi.org/10.1159/000351153</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId><ArticleId IdType="pmc">4049265</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur KC, Calvo A, Price TR, Geiger JT, Chi&#xf2; A, Traynor BJ (2016) Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun 7:12408. https://doi.org/10.1038/ncomms12408</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12408</ArticleId><ArticleId IdType="pubmed">27510634</ArticleId><ArticleId IdType="pmc">4987527</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoccolella S, Simone IL, Capozzo R, Tortelli R, Leo A, D&#x2019;Errico E, Logroscino G (2011) An exploratory study of serum urate levels in patients with amyotrophic lateral sclerosis. J Neurol 258(2):238&#x2013;243. https://doi.org/10.1007/s00415-010-5735-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-010-5735-9</ArticleId><ArticleId IdType="pubmed">20842370</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawton KA, Cudkowicz ME, Brown MV, Alexander D, Caffrey R, Wulff JE, Bowser R, Lawson R et al (2012) Biochemical alterations associated with ALS. Amyotroph Lateral Scler 13(1):110&#x2013;118. https://doi.org/10.3109/17482968.2011.619197</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.619197</ArticleId><ArticleId IdType="pubmed">22117131</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawton KA, Brown MV, Alexander D, Li Z, Wulff JE, Lawson R, Jaffa M, Milburn MV et al (2014) Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics. Amyotroph Lateral Scler Frontotemporal Degener 15(5-6):362&#x2013;370. https://doi.org/10.3109/21678421.2014.908311</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.908311</ArticleId><ArticleId IdType="pubmed">24984169</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Guo X, Huang R, Zheng Z, Chen Y, Shang H-F (2014) An exploratory study of serum creatinine levels in patients with amyotrophic lateral sclerosis. Neurol Sci 35(10):1591&#x2013;1597. https://doi.org/10.1007/s10072-014-1807-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-014-1807-4</ArticleId><ArticleId IdType="pubmed">24782098</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Wei Q-Q, Chen Y, Cao B, Ou R, Hou Y, Yuan X, Zhang L et al (2019) Clinical disease stage related changes of serological factors in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 20(1-2):53&#x2013;60. https://doi.org/10.1080/21678421.2018.1550516</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1550516</ArticleId><ArticleId IdType="pubmed">30784318</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith GD, Ebrahim S (2003) &#x2018;Mendelian randomization&#x2019;: can genetic epidemiology contribute to understanding environmental determinants of disease. Int J Epidemiol 32(1)</Citation></Reference><Reference><Citation>Burgess S, Thompson SG (2015) Mendelian randomization: methods for using genetic variants in causal estimation. Chapman &amp; Hall/CRC Press, London</Citation><ArticleIdList><ArticleId IdType="doi">10.1201/b18084</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinnott-Armstrong N, Tanigawa Y, Amar D, Mars NJ, Aguirre M, Venkataraman GR, Wainberg M, Ollila HM, Pirruccello JP, Qian J, Shcherbina A, Rodriguez F, Assimes TL, Agarwala V, Tibshirani R, Hastie T, Ripatti S, Pritchard JK, Daly MJ, Rivas MA (2019) Genetics of 38 blood and urine biomarkers in the UK Biobank. bioRxiv:660506. doi: https://doi.org/10.1101/660506</Citation></Reference><Reference><Citation>Kanai M, Akiyama M, Takahashi A, Matoba N, Momozawa Y, Ikeda M, Iwata N, Ikegawa S et al (2018) Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. Nat Genet 50(3):390&#x2013;400. https://doi.org/10.1038/s41588-018-0047-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0047-6</ArticleId><ArticleId IdType="pubmed">29403010</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ et al (2018) Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron 97(6):1268&#x2013;1283.e6. https://doi.org/10.1016/j.neuron.2018.02.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId><ArticleId IdType="pmc">5867896</ArticleId></ArticleIdList></Reference><Reference><Citation>Benyamin B, He J, Zhao Q, Gratten J, Garton F, Leo PJ, Liu Z, Mangelsdorf M et al (2017) Cross-ethnic meta-analysis identifies association of the GPX3-TNIP1 locus with amyotrophic lateral sclerosis. Nat Commun 8(1):611. https://doi.org/10.1038/s41467-017-00471-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00471-1</ArticleId><ArticleId IdType="pubmed">28931804</ArticleId><ArticleId IdType="pmc">5606989</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim H, Chasman DI, Smith JD, Mora S, Ridker PM, Nickerson DA, Krauss RM, Stephens M (2015) A multivariate genome-wide association analysis of 10 LDL subfractions, and their response to statin treatment, in 1868 Caucasians. PLoS ONE 10(4):e0120758. https://doi.org/10.1371/journal.pone.0120758</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0120758</ArticleId><ArticleId IdType="pubmed">25898129</ArticleId><ArticleId IdType="pmc">4405269</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce BL, Ahsan H, Vanderweele TJ (2011) Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol 40(3):740&#x2013;752. https://doi.org/10.1093/ije/dyq151</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyq151</ArticleId><ArticleId IdType="pubmed">20813862</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S et al (2018) The MR-Base platform supports systematic causal inference across the human phenome. Elife 7. https://doi.org/10.7554/eLife.34408</Citation></Reference><Reference><Citation>Verbanck M, Chen C-Y, Neale B, Do R (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 50(5):693&#x2013;698. https://doi.org/10.1038/s41588-018-0099-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0099-7</ArticleId><ArticleId IdType="pubmed">29686387</ArticleId><ArticleId IdType="pmc">6083837</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q, Wang J, Hemani G, Bowden J, Small DS (2020) Statistical inference in two-sample summary-data Mendelian randomization using robust adjusted profile score. Ann Statist 48(3):1742&#x2013;1769. https://doi.org/10.1214/19-AOS1866</Citation><ArticleIdList><ArticleId IdType="doi">10.1214/19-AOS1866</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Davey Smith G, Haycock PC, Burgess S (2016) Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40(4):304&#x2013;314. https://doi.org/10.1002/gepi.21965</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gepi.21965</ArticleId><ArticleId IdType="pubmed">4849733</ArticleId><ArticleId IdType="pmc">4849733</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44(2):512&#x2013;525. https://doi.org/10.1093/ije/dyv080</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyv080</ArticleId><ArticleId IdType="pubmed">4469799</ArticleId><ArticleId IdType="pmc">4469799</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan NA, Thompson JR (2016) Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol 45(6):1961&#x2013;1974. https://doi.org/10.1093/ije/dyw220</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyw220</ArticleId><ArticleId IdType="pubmed">27616674</ArticleId><ArticleId IdType="pmc">5446088</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, Jiang Y, Wedow R, Li Y, Brazel DM, Chen F, Datta G, Davila-Velderrain J et al (2019) Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use. Nat Genet 51(2):237&#x2013;244. https://doi.org/10.1038/s41588-018-0307-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0307-5</ArticleId><ArticleId IdType="pubmed">30643251</ArticleId><ArticleId IdType="pmc">6358542</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan Y, Fang F (2019) Smoking and amyotrophic lateral sclerosis: a Mendelian randomization study. Ann Neurol 85(4):482&#x2013;484. https://doi.org/10.1002/ana.25443</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25443</ArticleId><ArticleId IdType="pubmed">30786056</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X, Wang T, Chen Y, Shen Z, Gao Y, Xiao L, Zheng J, Zeng P (2020) Alcohol drinking and amyotrophic lateral sclerosis: an instrumental variable causal inference. Ann Neurol 88(1):195&#x2013;198. https://doi.org/10.1002/ana.25721</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25721</ArticleId><ArticleId IdType="pubmed">32196748</ArticleId></ArticleIdList></Reference><Reference><Citation>Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, Kanoni S, Ganna A, Chen J et al (2013) Discovery and refinement of loci associated with lipid levels. Nat Genet 45(11):1274&#x2013;1283. https://doi.org/10.1038/ng.2797</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2797</ArticleId><ArticleId IdType="pubmed">3838666</ArticleId><ArticleId IdType="pmc">3838666</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng P, Zhou X (2019) Causal effects of blood lipids on amyotrophic lateral sclerosis: a Mendelian randomization study. Hum Mol Genet 28(4):688&#x2013;697. https://doi.org/10.1093/hmg/ddy384</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy384</ArticleId><ArticleId IdType="pubmed">30445611</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemani G, Tilling K, Davey Smith G (2017) Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet 13(11):e1007081. https://doi.org/10.1371/journal.pgen.1007081</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007081</ArticleId><ArticleId IdType="pubmed">29149188</ArticleId><ArticleId IdType="pmc">5711033</ArticleId></ArticleIdList></Reference><Reference><Citation>Brion M-JA, Shakhbazov K, Visscher PM (2013) Calculating statistical power in Mendelian randomization studies. Int J Epidemiol 42(5):1497&#x2013;1501. https://doi.org/10.1093/ije/dyt179</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyt179</ArticleId><ArticleId IdType="pubmed">24159078</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber SC, Shaw PJ (2010) Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med 48(5):629&#x2013;641. https://doi.org/10.1016/j.freeradbiomed.2009.11.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2009.11.018</ArticleId><ArticleId IdType="pubmed">19969067</ArticleId></ArticleIdList></Reference><Reference><Citation>Bond L, Bernhardt K, Madria P, Sorrentino K, Scelsi H, Mitchell CS (2018) A metadata analysis of oxidative stress etiology in preclinical amyotrophic lateral sclerosis: benefits of antioxidant therapy. Front Neurosci 12:10. https://doi.org/10.3389/fnins.2018.00010</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00010</ArticleId><ArticleId IdType="pubmed">29416499</ArticleId><ArticleId IdType="pmc">5787557</ArticleId></ArticleIdList></Reference><Reference><Citation>Yusuf M, Khan M, Robaian MA, Khan RA (2018) Biomechanistic insights into the roles of oxidative stress in generating complex neurological disorders. Biol Chem 399(4):305&#x2013;319. https://doi.org/10.1515/hsz-2017-0250</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hsz-2017-0250</ArticleId><ArticleId IdType="pubmed">29261511</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzolino M, Carr&#xec; MT (2012) Mitochondrial dysfunction in ALS. Prog Neurobiol 97(2):54&#x2013;66. https://doi.org/10.1016/j.pneurobio.2011.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2011.06.003</ArticleId><ArticleId IdType="pubmed">21827820</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi AU, Mochly-Rosen D (2018) Mortal engines: Mitochondrial bioenergetics and dysfunction in neurodegenerative diseases. Pharmacol Res 138:2&#x2013;15. https://doi.org/10.1016/j.phrs.2018.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2018.08.010</ArticleId><ArticleId IdType="pubmed">30144530</ArticleId><ArticleId IdType="pmc">6263811</ArticleId></ArticleIdList></Reference><Reference><Citation>Cali&#xf3; ML, Henriques E, Siena A, Bertoncini CRA, Gil-Mohapel J, Rosenstock TR (2020) Mitochondrial dysfunction, neurogenesis, and epigenetics: putative implications for amyotrophic lateral sclerosis neurodegeneration and treatment. Front Neurosci 14:679. https://doi.org/10.3389/fnins.2020.00679</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00679</ArticleId><ArticleId IdType="pubmed">32760239</ArticleId><ArticleId IdType="pmc">7373761</ArticleId></ArticleIdList></Reference><Reference><Citation>Beal MF (2011) Neuroprotective effects of creatine. Amino Acids 40(5):1305&#x2013;1313. https://doi.org/10.1007/s00726-011-0851-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-011-0851-0</ArticleId><ArticleId IdType="pubmed">21448659</ArticleId></ArticleIdList></Reference><Reference><Citation>Deminice R, Portari GV, Vannucchi H, Jordao AA (2009) Effects of creatine supplementation on homocysteine levels and lipid peroxidation in rats. Br J Nutr 102(1):110&#x2013;116. https://doi.org/10.1017/S0007114508162985</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114508162985</ArticleId><ArticleId IdType="pubmed">19079843</ArticleId></ArticleIdList></Reference><Reference><Citation>Guimar&#xe3;es-Ferreira L, Pinheiro CHJ, Gerlinger-Romero F, Vitzel KF, Nachbar RT, Curi R, Nunes MT (2012) Short-term creatine supplementation decreases reactive oxygen species content with no changes in expression and activity of antioxidant enzymes in skeletal muscle. Eur J Appl Physiol 112(11):3905&#x2013;3911. https://doi.org/10.1007/s00421-012-2378-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00421-012-2378-9</ArticleId><ArticleId IdType="pubmed">22415102</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenz H, Schmidt M, Welge V, Schlattner U, Wallimann T, Els&#xe4;sser H-P, Wittern K-P, Wenck H et al (2005) The creatine kinase system in human skin: protective effects of creatine against oxidative and UV damage in vitro and in vivo. J Invest Dermatol 124(2):443&#x2013;452</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0022-202X.2004.23522.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Fimognari C, Sestili P, Lenzi M, Cantelli-Forti G, Hrelia P (2009) Protective effect of creatine against RNA damage. Mutat Res 670(1-2):59&#x2013;67. https://doi.org/10.1016/j.mrfmmm.2009.07.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrfmmm.2009.07.005</ArticleId><ArticleId IdType="pubmed">19631670</ArticleId></ArticleIdList></Reference><Reference><Citation>Sestili P, Martinelli C, Bravi G, Piccoli G, Curci R, Battistelli M, Falcieri E, Agostini D et al (2006) Creatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activity. Free Radic Biol Med 40(5):837&#x2013;849</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2005.10.035</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Calvo A, Bovio G, Canosa A, Bertuzzo D, Galmozzi F, Cugnasco P, Clerico M et al (2014) Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study. JAMA Neurol 71(9):1134&#x2013;1142. https://doi.org/10.1001/jamaneurol.2014.1129</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.1129</ArticleId><ArticleId IdType="pubmed">25048026</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>